Dr Michael Winlo has extensive experience in leading high-growth teams across the biotech, pharmaceutical and technology sectors, and is currently the Managing Director of Emyria Limited (ASX:EMD).

Michael is also a Director and former CEO of Linear Clinical Research, a world-class provider of early and late stage pharmaceutical trials.

Prior to this he was the health lead for Palantir Technologies (Silicon Valley), one of the worlds largest big data companies. There, he led deployments for health and government organisations across the US and UK.

Michael has a Master of Business Administration (MBA) from Stanford University and a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Western Australia.